1. Home
  2. CTRI vs IDYA Comparison

CTRI vs IDYA Comparison

Compare CTRI & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRI
  • IDYA
  • Stock Information
  • Founded
  • CTRI 1909
  • IDYA 2015
  • Country
  • CTRI United States
  • IDYA United States
  • Employees
  • CTRI N/A
  • IDYA N/A
  • Industry
  • CTRI
  • IDYA Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTRI
  • IDYA Health Care
  • Exchange
  • CTRI Nasdaq
  • IDYA Nasdaq
  • Market Cap
  • CTRI 1.8B
  • IDYA 2.0B
  • IPO Year
  • CTRI 2024
  • IDYA 2019
  • Fundamental
  • Price
  • CTRI $20.42
  • IDYA $21.67
  • Analyst Decision
  • CTRI Hold
  • IDYA Strong Buy
  • Analyst Count
  • CTRI 7
  • IDYA 12
  • Target Price
  • CTRI $19.00
  • IDYA $54.27
  • AVG Volume (30 Days)
  • CTRI 908.3K
  • IDYA 1.2M
  • Earning Date
  • CTRI 07-28-2025
  • IDYA 08-05-2025
  • Dividend Yield
  • CTRI N/A
  • IDYA N/A
  • EPS Growth
  • CTRI N/A
  • IDYA N/A
  • EPS
  • CTRI 0.00
  • IDYA N/A
  • Revenue
  • CTRI $2,659,287,000.00
  • IDYA $7,000,000.00
  • Revenue This Year
  • CTRI $5.94
  • IDYA $101.20
  • Revenue Next Year
  • CTRI $5.40
  • IDYA $286.70
  • P/E Ratio
  • CTRI $4,514.00
  • IDYA N/A
  • Revenue Growth
  • CTRI N/A
  • IDYA N/A
  • 52 Week Low
  • CTRI $14.46
  • IDYA $13.45
  • 52 Week High
  • CTRI $26.84
  • IDYA $44.42
  • Technical
  • Relative Strength Index (RSI)
  • CTRI N/A
  • IDYA 58.21
  • Support Level
  • CTRI N/A
  • IDYA $21.09
  • Resistance Level
  • CTRI N/A
  • IDYA $22.50
  • Average True Range (ATR)
  • CTRI 0.00
  • IDYA 0.97
  • MACD
  • CTRI 0.00
  • IDYA -0.04
  • Stochastic Oscillator
  • CTRI 0.00
  • IDYA 56.44

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings primarily consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. They operate under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: